Pregnenolone for the Treatment of Alcohol Use Disorder
Status:
Not yet recruiting
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
This Phase 2 randomized cotrolled trial (RCT) will assess the safety and efficacy of
pregnenolone (PREG; 300 mg/day, b.i.d dosing) vs. placebo (PBO) over a 12 week treatment
period, and at 1-month post-treatment follow-up in individuals with Alcohol Use Disorder
(AUD).